TABLE 1: Characteristics of patients with long-term detectable serum-specific anti-chikungunya IgM antibodies (CHIKV-IgM) at the Hospital das ClĂnicas, Universidade Federal de Pernambuco, Brazil.
Patients | Demographics1 | Comorbidities2 | Symptoms in acute phase | Persistent joint pain | Time since acute infection (months) |
---|---|---|---|---|---|
1 | 63y, M, White | MG, HTN | Fever/joint pain | Yes | 15 |
2 | 50y, F, Nonwhite | HTN, DM | Fever/joint pain/rash | No | 23 |
3 | 60y, F, Nonwhite | HTN, DM | Fever/joint pain | Yes | 24 |
4 | 69y, F, Nonwhite | HTN | Joint pain/rash | Yes | 32 |
5 | 51y, F,Nonwhite | - | Fever/joint pain/rash | Yes | 32 |
6 | 44y, F, Nonwhite | HTN | Fever/joint pain/rash | Yes | 34 |
7 | 39y, F, White | - | Fever/joint pain | Yes | 35 |
Age (years); Sex (M=male, F=female), race; 2MG: membranous glomerulopathy; HTN: hypertension; DM: diabetes mellitus.